I Asked 6 Apple Growers and Bakers To Name the Best Apple for Baking—They All Said the Same Thing FDA approves first new ... President Trump signs aviation safety executive order 30 Incredibly ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication ... developed the new drug. The FDA's sign-off on the medication comes as the ...

A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday ... "It has no sign of addiction, which makes it a hugely important new tool as we ...

A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex, is ...

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer with disease progression after endocrine therapy. The Food and Drug ...

Vertex Pharmaceuticals has scored an FDA approval for Journavx (suzetrigine), a non-opioid pain reliever that could usher in a new era of nonaddictive therapy in the indication. As an oral voltage ...

Ozempic is already widely used and was first FDA-approved in 2017 to treat type 2 ... Alcohol Cravings Getty Never miss a story — sign up for PEOPLE's free daily newsletter to stay up-to-date ...

Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval ...